An Early Olfactory Transcriptomic Signature of Tauopathy: Gbp2b Emerges as a Candidate Biomarker of Tau-Driven Neuroinflammation
Dourte, M.; Bouloki, A.; Dieu, M.; Magomadov, M.; Paitre, E.; Suelves, N.; Renard, P.; Kienlen-Campard, P.
Show abstract
Olfactory dysfunction is increasingly recognized as an early feature of neurodegenerative diseases such as Alzheimers disease. PS19 mice, a well-established tauopathy model, exhibit hallmarks of tau pathology--including hyperphosphorylated tau and pretangle formations--in various regions of the olfactory system. Notably, very recent data demonstrated that aberrantly hyperphosphorylated tau (pTau) was detected as early as 1.5 months of age in the olfactory epithelium (OE). This region contains olfactory sensory neurons projecting to the olfactory bulb (OB), where similar pTau pattern was also observed at this early stage. By 6 months, tau pretangles were evidenced in higher olfactory areas such as the piriform and entorhinal cortices. Given the early involvement of the OE and OB in tau pathology, we performed transcriptomic analyses at 3, 6, and 9 months to investigate the molecular pathways underlying tau pathology in these olfactory regions. Due to the OEs peripheral location and anatomical accessibility, we also aimed in that respect to identify potential early biomarkers of tauopathy. The hippocampus, a key brain region affected in Alzheimers disease and related disorders, was included in the analysis as a comparative reference due to its known vulnerability and clinical relevance. Our analyses revealed region- and age-specific gene expression changes in PS19 mice. Functional enrichment analyses indicated a temporal progression of molecular alterations associated with tau pathology. We identified a subset of genes differentially expressed across different time points and/or regions. Among these, Gbp2b emerged as a particularly promising early biomarker candidate for tauopathy in the OE, showing consistent upregulation across tau pathological stages and brain regions. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=152 SRC="FIGDIR/small/662324v1_ufig1.gif" ALT="Figure 1"> View larger version (43K): org.highwire.dtl.DTLVardef@17148c1org.highwire.dtl.DTLVardef@5fa7dborg.highwire.dtl.DTLVardef@51e21org.highwire.dtl.DTLVardef@1fd4302_HPS_FORMAT_FIGEXP M_FIG Created in BioRender. Kienlen-Campard, P. (2025) https://BioRender.com/k7xoypd C_FIG
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Neuropathological assessment of the olfactory bulb and tract in individuals with COVID-19 96%
- Protein farnesylation is upregulated in Alzheimer's human brains and neuron-specific suppression of farnesyltransferase mitigates pathogenic processes in Alzheimer's model mice 96%
- Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction, progression, and prion-like spread of Alzheimer s disease pathogenesis 96%
Similar papers in this journal
- Probe-dependent Proximity Profiling (ProPPr) Uncovers Similarities and Differences in Phospho-Tau-Associated Proteomes Between Tauopathies 96%
- Diabetic phenotype in mouse and humans with β-amyloid pathology reduces the number of microglia around β-amyloid plaques 96%
- Genetic perturbations of disease risk genes in mice capture transcriptomic signatures of late-onset Alzheimer’s disease 96%
Similar papers in this journal
- The Olfactory Epithelium: A Critical Gateway for Pathological Tau Propagation and a Target for Mitigating Tauopathy in the Central Nervous System 98%
- Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome-Alzheimer's disease 97%
- Genome-wide association study and functional validation implicates JADE1 in tauopathy 95%
Similar papers in this journal
- Retinal tau phosphorylation in Alzheimer's disease: a mass spectrometry study 96%
- Non-linear microglial, inflammatory and oligodendrocyte dynamics across stages of Alzheimer's disease 95%
- Regional interneuron transcriptional changes reveal pathologic markers of disease progression in a mouse model of Alzheimer's disease 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.